This article is a correction to:
Precision medicine: a new era for inner ear diseases
Elisa Tavazzani1,2*†
Paolo Spaiardi3,4*†
Donatella Contini5
Giulio Sancini6,7‡
Giancarlo Russo8‡
Sergio Masetto8‡- 1Department of Molecular Medicine, University of Pavia, Pavia, Italy
- 2ICS-Maugeri IRCCS, Pavia, Italy
- 3Department of Biology and Biotechnology “Lazzaro Spallanzani”, University of Pavia, Pavia, Italy
- 4Istituto Nazionale di Fisica Nucleare, Sezione di Pavia, Pavia, Italy
- 5Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, United States
- 6Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
- 7Nanomedicine Center, Neuroscience Center, School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
- 8Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy
A Corrigendum on
Precision medicine: a new era for inner ear diseases
by Tavazzani E, Spaiardi P, Contini D, Sancini G, Russo G and Masetto S (2024). Front. Pharmacol. 15:1328460. doi: 10.3389/fphar.2024.1328460
In the published article, there was an error in the Funding statement. The CUP numbers were missed. “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The fee of this publication is supported by the following grants: FIS. SPAIA.PRIN 2022; PRIN 2022 funded by the European Union–Next-Generation EU, PRIN 20228AAJRL; PRIN 2022 funded by the European Union–Next-Generation EU, 2023-ATEQC-0026—multifunctional nanocarriers as advanced biomaterials for targeted and therapeutic RNA delivery [MixnMatch] financed to: SP, MS, and SG respectively” and include original text. The correct Funding statement appears below.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The fee of this publication is supported by the following grants: FIS. SPAIA.PRIN 2022; PRIN 2022 funded by the European Union–Next-Generation EU, CUP F53D23006030001; PRIN 20228AAJRL; PRIN 2022 funded by the European Union–Next-Generation EU, CUP F53D23005930006; 2023-ATEQC-0026—multifunctional nanocarriers as advanced biomaterials for targeted and therapeutic RNA delivery [MixnMatch] financed to: SP, MS, and SG respectively.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: vestibule, cochlea, inner ear, nanoparticles, microneedles, precision medicine
Citation: Tavazzani E, Spaiardi P, Contini D, Sancini G, Russo G and Masetto S (2024) Corrigendum: Precision medicine: a new era for inner ear diseases. Front. Pharmacol. 15:1385698. doi: 10.3389/fphar.2024.1385698
Received: 13 February 2024; Accepted: 14 February 2024;
Published: 27 February 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Tavazzani, Spaiardi, Contini, Sancini, Russo and Masetto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Elisa Tavazzani, elisa.tavazzani@unipv.it; Paolo Spaiardi, paolo.spaiardi@unipv.it
†These authors have contributed equally to this work and share first authorship
‡These authors share senior authorship